RBSC

**Sir X** · October 28, 2011, 05:13 PM

The 1st thing OJ in the left hand corner of the article it says Propoganda! where is the source ?

Of note there is no author, if you notice the source is a large netherlands
study ? Thats an open interpretation.

Ganja in Jamaica: The Effects of Marijuana Use.A US GOVERNMENTAL STUDY.

DR:Rubin, Vera, and Comitas, Lambros.(1976).
Garden City, NY: Anchor.

ISBN: 0-385-12172-5

Description: Paperback, xxii + 217 pages.

Contents: Foreword by Raymond Philip National [US] Commission on Marihuana and Drug Abuse, preface, acknowledgements, Jamaica Project Staff, 12 chapters, 8 appendices: A. " Ganja Smoking as a Danger to the Natives of this Colony," (Editorial from Daily Gleaner, Jamaica, June 10, 1913); B. Summary of ganja legislation in Jamaica, 1913-1972; C. Laboratory Analyses of ganja samples; D. Demographic profile of clinical sample based on life histories; E. Chromosome studies, steroid excretion and peripheral thyroid hormone levels; F. Estimated THC content of cannabis used in the U.S. and other countries; G. Responses to questions concerning reaction to first experiences with ganja & Responses to questions concerning subsequent experiences with ganja; H. Life expectancy table; bibliography.

Note: This book was originally published in hardcover as Ganja in Jamaica: A Medical Anthropological Study of Chronic Marijuana Use in 1975 by Mouton & Co.

Excerpt(s): Dragons in dark caves, Justice Oliver Wendell Holmes once reminded us, are far more fearsome than when they are seen in daylight. How refreshing it is, therefore, to have available an objective study which not only exposes but also demolishes many emotional and "fright-symbolic" dragons which have clouded our perspective in recent years with reference to cannabis. It is refreshing, also, to see the results of so many individuals and institutions working together, scientifically, separating "fact from fiction" in an area so important to human beings everywhere, namely, the use of a psychotropic substance such as marihuana.

The Jamaica study, sponsored by the Center for Studies of Narcotic and Drug Abuse, National Institute of Mental Health, was the first project in medical anthropology to be undertaken and is the first intensive, multidisciplinary study of marihuana use and users to be published. (Foreword, Raymond Philip Shafer, pages v-vi)

... Almost unanimously, informants categorically stated that ganja, particularly in spliff form, enabled them to work harder, faster and longer. For energy, ganja is taken in the morning, during breaks in the work routine or immediately before particularly onerous work.

The belief that ganja acts as a work stimulant and the behavior that this induces casts considerable doubt on the universality of what has been described in the literature as "the amotivational syndrome," or a "loss of desire to work, to compete, to face challenges. Interests and major concerns of the individual become centered around marijuana and drug use becomes compulsive." In Jamaica, and one would suspect other cannabis-using agricultural countries, ganja is central to a "motivational syndrome," at least on the ideational level. Ganja, in the cultural setting of rural Jamaica, rather than hindering, permits its users to face, start and carry through the most difficult and distasteful manual labor. (page 58)

In addition, ganja, unlike alcohol, has special symbolic attributes. Rastafarian metaphysics, for example, emphasizes and brings into focus general concepts derived from working-class views of ganja. For them, it is "the wisdom weed," of divine origin, an elixir vitae, documented by Biblical chapter and verse which over-rides man-made proscriptions. Religious authority thus validates and fortifies commitment to its use; ... the sacred source of ganja permits a sense of religious communion, marked by meditation and contemplation. (page 151)

The psychiatric findings do not bear out any of the extreme allegations about the deleterious effects of chronic use of cannabis on sanity, cerebral atrophy, brain damage or personality deterioration. There is no evidence of withdrawal symptoms or reports of severe overdose reactions or of physical dependency. The psychological findings show no significant differences between long-term smokers and non-smokers.

Over the past one hundred years, the ganja complex has developed and proliferated in Jamaican society and is extraordinarily well integrated into working-class life styles. Ganja serves multiple purposes that are essentially pragmatic, rather then psychedelic: working-class users smoke ganja to support rational task-oriented behavior, to keep "conscious," fortify health, maintain peer group relations and enhance religious and philosophical contemplation. They express social rather than hedonistic motivations for smoking.

Ganja as an energizer is the primary motivation given for continued use. ...

The failure of policy makers to realize the importance of informal social controls in preventing drug abuse is beginning to be recognized. Michael Sonnenreich, Vice-President of the National Coordinating Council on Drug Education in the United States, observed that drug-taking is socially controlled "when it is routinized, ritualized and structured so as to reduce to a minimum any drug-taking behavior the surrounding culture considers inadvisable. From this analysis there should follow a new approach." The multidisciplinary findings reported in this volume highlight the underlying role of culture in regulating the use of ganja and conditioning reactions to it-within a structured system of social controls. (Summary, pages 172-3)

President:Jimmy Carter to congress:U.S. President Jimmy Carter: "Penalties against drug use should not be more damaging to an individual than the use of the drug itself. Nowhere is this more clear than in the laws against the possession of marijuana in private for personal use."

**Sir X** · October 28, 2011, 05:24 PM

A movie you need to watch , I dont think you know the history of ganja to really debate this issue , 1st let me enlighten you ganja was legal in the USA up to the 1930s , the founding fathers said "Make the most you can of the Indian Hemp seed and sow it everywhere."
- George Washington, U.S. President quote on Hemp

Reefer Madness(Tell Your Children / Dope Addict / Doped Youth / Love Madness / The Burning Question)
1936 NR 66 minutes
Video:http://www.youtube.com/watch?v=QLLLT...eature=related

This 1936 propaganda film took on a life of its own when the National Organization for the Reform of Marijuana Laws dug it out of the Library of Congress in the early 1970s. Since then, the movie has become a cult hit among modern audiences, who appreciate the story line's comedic value. In short, a group of teens seduced by the power of "reefer" take a few puffs -- and instantly become psychotic killers, jazz addicts and whores.

Read these quotes from some of our Founding fathers , Ganja was also piggy backed through congress to be made illegal that it drove men of color to whistle to white women....we continue to perpetuate that racist myth...dats where di term ganja mek yuh mad come from.
http://eazysmoke.com/marijuana-quotes.htm

Ask yourself a simple question if it is as you say associated with driving us mad and lazy , through all the history books of the past that has never been recorded on the contray is a healing herb, only recently since Reagan declared his war on drugs has all this baseless scientific evidence come up.

Incidentally the evidence is so weak that it is legal in the entire West and SW from Nevada - Cali to Washington.

Ganja does nothing to make you crazy , it inhibts the signs or draws it out, in other words yuh born mad or something else a mad yuh.

**Sir X** · October 28, 2011, 05:38 PM

The best one yet :
The Union: The Business Behind Getting High
2007 NR 104 minutes
Filmmaker Adam Scorgie explores the illegal marijuana industry in British Columbia, revealing how the international business is most likely more profitable than it would be if it was lawful in this enlightening documentary. Marijuana growers, law enforcement officials, physicians, politicians, criminologists, economists and celebrities -- including comedian Tommy Chong -- shed light on this topical subject in a series of compelling interviews.

Video:http://www.youtube.com/watch?v=kUU2YB9OgaU

**Sir X** · October 28, 2011, 05:45 PM

Watch up to 7:50 of the movie to get a judge findings on ganja after taking medical testimoy for over two weeks.

http://www.youtube.com/watch?v=lmt3m...eature=related

A nuh me say suh , its in black and white.

**Sir X** · October 28, 2011, 05:48 PM

Personal evidence , I know MDs who burn ganja and work damm well ,I know some who dont and are damm crazy in terms of competence.Had to tell a MD chill , that odor is too strong. I know people who dont smoke ganja and are crazy.

Beside the smoke ,its o.k .We cannot blame ganja for our social ills, high unemployment leads to the wrong perception that the youths are lazy and crazy , when in reality the bible tells you ..idle hands leads to the devils work.... but its easier to blame the weed. .... ..goodnight.

OJ · October 28, 2011, 05:51 PM

Having 5 post and saying the same thing over and over again does not make it fact. Its is that kind of attitude that creates a stigma around mental health. Go ask a doctor if there is a link. That is like saying tar does not cause cancer. it does not mean it causes cancer in everyone but it can. Marij use can lead to psychosis. They are many kids who are alergic just as you can be allergic to peanuts.. Whats wrong with you.. It is not a opinion it is a fact.

Journal List > BMC Psychiatry > v.5; 2005
Formats:

Abstract |
Full Text |
PDF (250K)

Performing your original search, thc and pychosis, in PubMed Central will retrieve 0 records.

BMC Psychiatry. 2005; 5: 17.
Published online 2005 April 1. doi: 10.1186/1471-244X-5-17

PMCID: PMC1079888
Copyright © 2005 Favrat et al; licensee BioMed Central Ltd.
Two cases of "cannabis acute psychosis" following the administration of oral cannabis
Bernard Favrat,1 Annick Ménétrey,2 Marc Augsburger,2 Laura E Rothuizen,3 Monique Appenzeller,3 Thierry Buclin,3 Marie Pin,1 Patrice Mangin,2 and Christian Giroud2
1Unité de Médecine du Trafic, Institut Universitaire de Médecine Légale (IUML), 1005 Lausanne, Switzerland
2Laboratoire de Toxicologie et Chimie Forensiques (LTCF), Institut Universitaire de Médecine Légale (IUML), Rue du Bugnon 21, 1005 Lausanne, Switzerland
3Division de pharmacologie et toxicologie cliniques, CHUV, 1011 Lausanne, Switzerland
Corresponding author.
Bernard Favrat: bernard.favrat@hospvd.ch; Annick Ménétrey: amenetrey@debio.com; Marc Augsburger: Marc.Augsburger@hospvd.ch; Laura E Rothuizen: Laura.Rothuizen@hospvd.ch; Monique Appenzeller: Monique.Appenzeller@chuv.hospvd.ch; Thierry Buclin: Thierry.Buclin@chuv.hospvd.ch; Marie Pin: Marie.Pin@hospvd.ch; Patrice Mangin: Patrice.Mangin@hospvd.ch; Christian Giroud: Christian.Giroud@hospvd.ch
Received January 21, 2005; Accepted April 1, 2005.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

This article has been cited by other articles in PMC.

Other Sections▼

Abstract

Background
Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest. Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users.

Case presentations
We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed transient psychotic symptoms (depersonalization, paranoid feelings and derealisation) following oral administration of cannabis. In contrast to most other case reports where circumstances and blood concentrations are unknown, the two cases reported here happened under experimental conditions with all subjects negative for cannabis, opiates, amphetamines, cocaine, benzodiazepines and alcohol, and therefore the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels were documented.

Conclusion
While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur.

Other Sections▼

Background

As several countries in Europe have taken policies to decrease the penalties for cannabis possession, many people especially young persons have interpreted this move as giving support to consider cannabis as a benign drug [1].
However as stated by several reports cannabis is not a harmless substance and requires urgent attention considering public health issues such as car driving for example [2]. The relationship between Cannabis and acute psychosis is another important issue. In Pakistan and also India, Bhang, a beverage made from an infusion of cannabis leaves, and flowering tops combined with milk and nuts is reported to frequently induce psychotic manifestations among consumers [3]. Presenting symptoms include grandiosity, excitement, hostility, uncooperativeness, disorientation, hallucinatory behaviour and unusual thought content [3].
Recently five large-scale longitudinal studies and a systematic review have shown that cannabis use in adolescence is associated with a two-to threefold increase in the relative risk of later developing schizophrenia [4]. Furthermore short-term psychotic reactions, particularly in naive users have also been reported. Thomas [5] describes that one in seven people reported psychotic-like symptoms. Such reactions are usually acute, transient, self-limited however very unpleasant ("hearing voices, becoming convinced that someone is trying to harm you or that you are persecuted") [6]. But cannabinoids are considered able to trigger long-lasting psychotic decompensations in predisposed individuals, which may in part account for the epidemiological association described between cannabis consumption and psychotic disorders [7,8].
The therapeutic aspects of cannabis represent additional issues, as they are in constant development since several years. Synthetic THC (dronabinol) is available for restricted medical use in the USA since 1985. Nabilone, a synthetic THC analogue, is licensed in UK for the treatment of nausea and vomiting caused by chemotherapy unresponsive to usual anti-emetics. Clinical applications actually include nausea and vomiting, muscle spasticity in demyelinating diseases, loss of appetite in cancer and AIDS, pain, insomnia, asthma as well as other applications [9].
As these oral medications are becoming increasingly available, we think it is useful to report two cases of severe psychological sides effects, especially considering the lack of data in the literature on psychotic symptoms associated with oral synthetic or natural THC.

Other Sections▼

Case reports

We report two cases out of 8 healthy male volunteers who were included in a double blind crossover clinical study, approved by the ethics committee of the Department of Internal Medicine of the University of Lausanne. All subjects had to be occasional but regular cannabis users. Their urines were controlled to be negative for any drug of abuse (cannabis, opiates, amphetamines, cocaine, benzodiazepines) before each study period. The presence of ethanol was checked using a breathalyzer. All of them provided their written informed consent. This study was carried out to assess the effects of delta-9-tetrahydrocannabinol (THC) on psychomotor function and driving performance. It compared a medication containing 20 mg dronabinol (MarinolR), and 2 hemp milk decoction containing either a medium (15.8 mg average dose determination) or a high dose of THC (45.7 mg) with matched placebos. The hemp plant fragments containing 1.5 % THC and 4.4 % THC-A were provided by Hiscia institute in Arlesheim, Switzerland. After administration, blood was sampled at regular intervals for cannabinoids determination by gas chromatography coupled with mass spectrometry (GC-MS-NCI). Clinical observations and 2 psychometric tests (roadsign recognition speed and accuracy on a tracking task) were also carried out. Furthermore, the subjects were asked to report their willingness to drive and the subjective effects on a VAS scale extending from 0 to 10 cm. The effects were assessed against placebo.
These 2 cases were withdrawn from the study because of adverse events. We consider them worth reporting for the following reasons: in contrast to most other case reports where circumstances and blood concentrations are not known, our two cases reported here happened under defined clinical setting: the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels are fully documented. In addition, the consumption of other psychotropic major drugs could be ruled out.
Case 1
The first subject was a 22-year-old medical student (weight: 65.3 kg, height: 1.82 m) and occasional cannabis smoker (about once per week). One hour after the administration of 20 mg of dronabinol, he started to laugh a lot and after 90 minutes, he manifested a severe anxiety with symptoms of derealisation and depersonalization. He reported "watching himself lying on the bed" and repeated several times the same questions at just a few minutes interval. Starting 2.5 hours after ingestion of dronabinol, and at the 4 hours and 5.5 hours post-ingestion series of tests, he was unable to perform the psychomotor tasks, despite reporting of weakening of symptoms approximately 165 minutes after their initiation. Before going to sleep (more than 10 hours after ingestion), he again felt a transient feeling of irrational anxiety and loosing the perception of his body. The next day he was well but a bit tired.
Figure Figure11 shows the evolution of his blood concentrations of cannabinoids after ingestion of 20 mg dronabinol. At the time of strong adverse effects, the blood levels of THC and 11-OH-THC reached a concentration of 1.8 and 5.2 ng/mL, respectively. The subject reported a strong feeling of intoxication (figure (figure2).2). He also evaluated that his driving capability was strongly impaired (figure (figure22).

Figure 1Whole blood concentrations of THC, 11-OH-THC (actives metabolites) and THC-COOH (inactive metabolite) after oral intake of 20 mg dronabinol and of a hemp milk decoction containing traces of cannabinoids (placebo).

Figure 2Subjective effects (feeling of intoxication or driving capability) after oral intake of 20 mg dronabinol. The subject reported no feeling of intoxication or of driving impairment after ingestion of the placebo.

Case 2
A 22-year-old student, also an occasional cannabis smoker (about twice a month), felt paranoid delusions with severe anxiety one hour after the administration of 16.5 mg of a THC decoction, and became suspicious during the experiment. He thought the investigators were concealing some problems. He was unable to perform the psychometric tests (roadsign recognition speed and accuracy on a tracking task) at the 1 hour and 2.5 hours post-ingestion series of tests. These effects persisted up to 4 hours after ingestion and weakened over the next 3 hours. The feeling was very unpleasant in comparison with that experienced after his usual smoking cannabis consumption.
On the next day, he was well, with no recurrence. The time-concentration curves for the major cannabinoids were similar to those observed after ingestion of 20 mg dronabinol. One hour after drinking the hemp decoction, the THC and 11-OH-THC blood levels were of 6.2 and 3.9 ng/mL, respectively. Similarly to the other volunteer, he also indicated a strong feeling of intoxication and a very important decrease in his self-reported capacity to drive (results not shown).

Other Sections▼

Conclusion

A temporary form of drug-induced psychotic reaction after administration of oral cannabis has occurred in these two cases. Cannabis psychosis is the term proposed in the literature [10]. In 1958, Ames [11] reported in an experimental design with 10 subjects psychological symptoms such as severe anxiety, panic attacks, paranoid delusions and depersonalization. Talbott [12] in 1969 described 12 soldiers in Vietnam who had disorientation and hallucinations after their first use of cannabis. In Germany, 19 cases of toxic psychosis were reported after hashish use [13] and in Calcutta, Chopra [14] described retrospectively 200 patients hospitalized after the ingestion of large dose of cannabis between 1963 and 1968. Other reports in different countries showed similar features after bhang ingestion [3,15]. It usually results from taking large amount of the drug, generally in food or drink. The symptoms have some similarity with paranoid schizophrenia, which could raise the hypothesis that " symptoms of schizophrenic illness might be caused by an abnormal over-activity of endogenous cannabinoid mechanism in the brain" (Iversen [10] citing Emrich [16]). However because of the poor quality of information on previous cannabis experience, cannabis dose intake, other drug consumption and previous psychiatric comorbidity, some commentators have criticized these case series [12,17,18]. Case-control studies have been conducted comparing people with cannabis psychosis with persons suffering from schizophrenia [19-21]. However the results were inconsistent due in part to the small sample size of these studies.
The originality of our two cases is that they were observed in an experimental setting, and therefore adds more evidence for the ability of oral cannabis to produce psychotic symptoms. In both our subjects, the effects appeared 1 hour to 1.5 hours after oral drug intake and lasted for 3 to 4 hours. Dronabinol (synthetic THC) is reported to have an onset of action at approximately 0.5 to 1 hour and peak effects between 2 and 4 hours. Psychoactive effects last 4 to 6 hours but the appetite stimulant effect may continue for 24 hours [22].
The issue of THC dose level is very important in terms of public health. A traditional cigarette of herbal cannabis in the 1960s and 1970s contained 1–3% THC: for a joint made of 750 mg of cannabis plant, the corresponding THC amount was 7 to 20 mg. However, the actual amount of cannabis taken up (i.e. the percent delivery to the respiratory tree) strongly depends on the smoking technique; it has been reported to reach approximately 50% [23]. Modern cigarettes (joint) based on intensive cannabis selection and improvement in plant cultivation contain 6 to 30% THC. Therefore, an average joint would correspond to 75 mg to 225 mg of THC! [22].
Through smoking, a 3.5% marijuana cigarette with about 900 mg plant materials can achieve plasma concentration in the range of 50 to 100 ng/ml. The maximum psychotropic effect or "high" occurs faster after smoking than by the oral route. Smoking is therefore the preferred route of cannabis administration for young users. Psychomotor function is considered to be obviously impaired above 10 ng/ml plasma THC for smoking cannabis. However in our two cases, the oral administration of cannabis produced circulating THC concentrations much lower than 10 ng/ml. We suggest several explanations for these differences. Firstly, the oral administration produces more active metabolite (11-OH-THC), which could more efficiently reach the effect site than THC. Secondly, as suggested by Chaudry [3], consuming oral cannabis may produce more potent, yet unknown psychotomimetic metabolites of THC. Thirdly, the slow absorption kinetics produces sustained plateau levels in the blood, which could influence the body and brain distribution. In a cocaine fatality, Giroud [24] found that THC and OH-THC were in higher concentration in brain than in blood.
Finally, Leweke [25] in a study including 17 healthy volunteers found also one case that suffered a two-hour episode of paranoid psychotic state following the administration of dronabinol with a lower dose than our study. Furthermore D'Souza [26] administrating intravenous THC to 22 healthy subjects in a double blind randomised clinical trial found a range of transient symptoms resembling those seen in endogenous psychosis. At last, it is important to differentiate these transient psychotic states with spontaneous resolution from the type of psychosis that persist beyond the persistence of drug in the brain, therefore probably indicating a worsening of an underlying pathologic problem.
In conclusion, doctors and users should be aware of the increasing availability of oral cannabis in "special" drinks or food as well as in medications under development. While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur. An increased incidence of psychotic episodes might be induced by this new trend and requires attention regarding this phenomenon in a public health perspective.

Competing interests

The author(s) declare that they have no competing interests.

Pre-publication history

The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/5/17/prepub

Acknowledgements

the financial support of the Swiss Federal Office of Public Health is warmly acknowledged (contract 02.001036 to LTCF/IUML). Mr Jérôme Tinguely is thanked for preparing the placebo capsules. Dr Frank Sporkert is strongly acknowledged for fruitful discussion.
Written consent was obtained from the patients for publication of study

Other Sections▼

References

Witton J, Murray RM. Reefer madness revisited: cannabis and psychosis. Rev bras Psiquiatr. 2004;26:2. [PubMed]
Ramaekers JG, Berghaus G, Van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004;73:109–119. doi: 10.1016/j.drugalcdep.2003.10.008. [PubMed] [Cross Ref]
Chaudry JM, Moss HB, Bashir A, Suliman T. Cannabis psychosis following bhang ingestion. British J Addiction. 1991;86:1075–1081.
Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:110–117. doi: 10.1192/bjp.184.2.110. [PubMed] [Cross Ref]
Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend. 1996;42:201–207. doi: 10.1016/S0376-8716(96)01277-X. [PubMed] [Cross Ref]
Hall W. Cannabis and psychosis. Drug Alcohol Rev. 1998;17:433–444. [PubMed]
Johns A. Psychiatric effect of cannabis. Br J Psychiatry. 2001;178:116–122. doi: 10.1192/bjp.178.2.116. [PubMed] [Cross Ref]
Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002;156:319–27. doi: 10.1093/aje/kwf043. [PubMed] [Cross Ref]
Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001;178:107–15. doi: 10.1192/bjp.178.2.107. [PubMed] [Cross Ref]
Iversen L. Cannabis and the brain. Brain. 2003;126:1252–1270. doi: 10.1093/brain/awg143. [PubMed] [Cross Ref]
Ames F. A clinical and metabolic study of acute intoxication with cannabis sativa and its role in the model psychoses. J Ment Sci. 1958;104:972–99. [PubMed]
Talbott JA, Teague JW. Marihuana psychosis: acute toxic psychosis associated with the use of cannabis derivatives. JAMA. 1969;210:299–302. doi: 10.1001/jama.210.2.299. [PubMed] [Cross Ref]
Tennant FS, Groesbeck CJ. Psychiatric effects of hashish. Arch Gen Psychiatry. 1972;27:133–136. [PubMed]
Chopra GS, Smith JW. Psychotic reactions following cannabis use in East Indians. Arch Gen Psychiatry. 1974;30:24–27. [PubMed]
Wylie AS, Scott RTA, Burnett SJ. Psychosis due to "shunk". BMJ. 1995;311:125. [PMC free article] [PubMed]
Emrich HM, Leweke FM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav. 1997;56:803–7. doi: 10.1016/S0091-3057(96)00426-1. [PubMed] [Cross Ref]
Thornicroft G. Cannabis and psychosis: is there epidemiological evidence for association. Br J Psychiatry. 1990;157:25–33. [PubMed]
Gruber AJ, Pope HG. Cannabis psychotic disorder: does it exist? Am J Addictions. 1994;3:72–83.
Thacore VR, Shukla SRP. Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry. 1976;33:383–386. [PubMed]
Rottamburg D, Robins AH, Ben-Arie O, Teggin A, Elk R. Cannabis-associated psychosis with hypomanic features. Lancet. 1982;2:1364–1366. doi: 10.1016/S0140-6736(82)91270-3. [PubMed] [Cross Ref]
Imade AGT, Ebie JC. A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand. 1991;83:134–136. [PubMed]
World Health Organization Cannabis a health perspective and research agenda. 1997. http://whqlibdoc.who.int/hq/1997/WHO_MSA_PSA_97.4.pdf
Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. Pharmacokinetics and metabolism of delta-9-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev. 1986;38:21–43. [PubMed]
Giroud C, Michaud K, Sporkert F, Eap C, Augsburger M, Cardinal P, Mangin P. A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluids and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry (HILIC-MS) J Anal Toxicol. 2004;28:464–474. [PubMed]
Leweke FM, Schneider U, Thies M, Munte TF, Emrich HM. Effects of synthetic D9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology. 1999;142:230–235. doi: 10.1007/s002130050884. [PubMed] [Cross Ref]
D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004;29:1558–72. doi: 10.1038/sj.npp.1300496. [PubMed] [Cross Ref]

Articles from BMC Psychiatry are provided here courtesy of
BioMed Central

PubMed related articles

Cannabis psychosis following bhang ingestion. [Br J Addict. 1991]
Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. [Schizophr Res. 2006]
Cannabinoid concentrations in hair from documented cannabis users. [Forensic Sci Int. 2007]
Review What is the mechanism whereby cannabis use increases risk of psychosis? [Neurotox Res. 2008]
Review Adverse effects of cannabis. [Prescrire Int. 2011]
» See reviews... | » See all...

Clear Turn Off

Two cases of "cannabis acute psychosis" following the administration of oral cannabis

[Reefer madness revisited: cannabis and psychosis]. [Rev Bras Psiquiatr. 2004]

ReviewDose related risk of motor vehicle crashes after cannabis use. [Drug Alcohol Depend. 2004]

ReviewCausal association between cannabis and psychosis: examination of the evidence. [Br J Psychiatry. 2004]
A community survey of adverse effects of cannabis use. [Drug Alcohol Depend. 1996]
Cannabis use and psychosis. [Drug Alcohol Rev. 1998]
ReviewPsychiatric effects of cannabis. [Br J Psychiatry. 2001]
Cannabis use and psychosis: a longitudinal population-based study. [Am J Epidemiol. 2002]

ReviewTherapeutic aspects of cannabis and cannabinoids. [Br J Psychiatry. 2001]

ReviewCannabis and the brain. [Brain. 2003]
A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. [J Ment Sci. 1958]
Marihuana psychosis. Acute toxic psychosis associated with the use of Cannabis derivatives. [JAMA. 1969]
Psychiatric effects of hashish. [Arch Gen Psychiatry. 1972]
Psychotic reactions following cannabis use in East Indians. [Arch Gen Psychiatry. 1974]

See more articles cited in this paragraph

ReviewPharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. [Pharmacol Rev. 1986]

A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS). [J Anal Toxicol. 2004]

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. [Psychopharmacology (Berl). 1999]
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. [Neuropsychopharmacology. 2004]

You are here: NCBI > Literature > PubMed Central
Write to the Help Desk

Simple NCBI Directory

NLM
NIH
DHHS
USA.gov

Copyright | Disclaimer | Privacy | Accessibility | Contact National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA

OJ · October 28, 2011, 06:00 PM

X I am dissapointed in you.. I know MD who burn ganja is NOT the point most of my friends do or did. I may have.. the point is it can cause psychosis and more and more people are becoming allergic. I saw an entire class room of kids who were in a hospital ward.. it is what it is.. The quicker we can acknowledge it the quicker we can help.. Weed is not for everyone....nor is alcohol. I expected you had some serious POV.. other than you know MDs and kings and queen... what that has to do with the issue....

**Sir X** · October 28, 2011, 06:05 PM

So ask yourself the simple question , if it drives us crazy or kills us why isnt Jamaicas crime rate attributed to ganja instead of Duduss, politics, and poverty , I mean we use it in our culture to smoke, cook and as medicine ?

You believe what you want to believe , I hope you evaluate the business of it , drug companies fighting to keep it illegal until they can patten it.

BTW each post has something different ...tek yuh time.

**Sir X** · October 28, 2011, 06:09 PM

Oj I addressed your point, dont be dissapointed in me , look at my points , each post has something of relevance.

1)The medical issue
2)The business
3)The political
4)The personal.

If yuh believe its all about mekking yuh crazy and killing yuh , yuh loss.Thats the half of it to justify big business and cultural ignorance.

That said you will believe what you want to believe.

**Sir X** · October 28, 2011, 06:15 PM

BTW when you look at studies and docu drama, ask yourself who sponsors them .Its an easy way to find out the bias in the documentary or study.

I have asked doctors and it depends on who you ask.I made it a point to ask a Psych MD, his opinion inconclusive....after how many studies.

**Plush** · October 28, 2011, 06:21 PM

I am cautiously touching this topic. I have a lot of friends who smokes ganja and most of them are lazy. I have a sibling who was an accountant and after smoking and partying he left his job to be in the streets. I have not seen much positive from Ganja so my personal decision would be to stay away from it...I would advice my friends to do the same as well because I don't know anyone who regularly smokes ganja and doesn't show effects from it...My personal opinion, without the studies, and reviews you guys are armed with

Me · October 28, 2011, 08:48 PM

I think most people who grow up in Jamaica have seen that from the man them who bun the herbs non stop.

You have some people (the minority as far as I have seen) who react negatively to it even from the slightest amount, like anything in life. However, instead of people accepting that some people can't manage it, them just run with the season spliff argument. Likewise, nuff people run with the it make people mad argument regardless of the person.

**Sir X** · October 28, 2011, 08:59 PM

I really cant buy the herb mek yuh lazy arguement .Jamaica has a high unmemployment rate , anything associated with negative social behavior, herb is an easy scape goat.

How do you explain it not having the same impact on the youths here in NYC.If a youth is lazy and non productive ganja is the last thing you would blame here.

If you think weed/ganja isnt a part of the culture here , you are wrong.Rap embraces and promotes ganja like reggae music does.NY is party central , where weed is one of the drugs of choice.

I know a lot of weed smokers that hold a 9-5.To me it seems like a waste of money to purchase an ounce or dime /20 bag of weed after a week of work , but others do it religously and party.

I cant see the lazyness in it.

I think Jamaicas mental health issues comes from its economic climate, what America is going through , Jamaica and third world nations have been going through for years.Third world nations take it for granted.The incidence of decreased mental health increased in this depression....hhhmmm...after the depression of the 30s how many people comitted suicide?Social crimes also increased.Now that is a link.

OJ · October 28, 2011, 09:54 PM

Again I have nothing against the herbs.. but as I said I witness a great deal of teens in a a treatment facility with one common issue. Alergy to Marij>> This was not a study a article its what I witness and to my surprise I was made aware by the professionals there that this is quite wide spread especially with the skunk and the hydro type weeds that is now on the market. Anyway I think you can play ostrich but it is what it it.. The quicker you understand the quicker you can help the next youth who may need help

RBSC

Announcement

Link between Phychosis and marijuana and alchol use

Link between Phychosis and marijuana and alchol use

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Comment